PHASE AND ELECTRON MICROSCOPIC OBSERVATIONS OF LEWY BODIES AND MELANIN GRANULES IN THE SUBSTANTIA NIGRA AND LOCUS CAERULEUS IN PARKINSONʼS DISEASE

1965/07/01 by PHILIP E. DUFFY, Philip E. Duffy, VIRGINIA M. TENNYSON +1 · 32 citations
Medicine · Neuroscience · Psychology · #Biology #Disease #Electron micrographs #Electron microscope #Medicine #Melanin #Neurological diseases and metabolism #Neurological disorders and treatments #Neuromelanin #Neuropathology #Neuroscience #Parkinson's Disease Mechanisms and Treatments #Parkinson's disease #Pathology #Physics #Psychology #Substantia nigra

paper · doi:10.1097/00005072-196507000-00003

openalex publication_date 1965/07/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/15

Abstract

Philip E. Duffy, M.D., Virginia M. Tennyson, Ph.D.; Phase and Electron Microscopic Observations of Lewy Bodies and Melanin Granules in the Substantia Nigra

Cited by

• The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
• Immunoreactivity of myelin‐associated oligodendrocytic basic protein in Lewy bodies
• 3D imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale x‐ray phase‐contrast tomography
• Parkinson's Disease
• Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
• Aromatic Amino Acids and Modification of Parkinsonism
• Intraneuronal dopamine-quinone synthesis: A review
• Presenile dementia with Alzheimer-, Pick- and Lewy-body changes
• The Synucleinopathies: Twenty Years On
• 100 years of Lewy pathology
• Modeling Parkinson's disease using induced pluripotent stem cells. [europepmc]
• Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration. [europepmc]
• Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease. [europepmc]
• Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease. [europepmc]
• A novel structure associated with aging is augmented in the DPP6-KO mouse brain. [europepmc]
• The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy. [europepmc]
• α-Synuclein-mediated neurodegeneration in Dementia with Lewy bodies: the pathobiology of a paradox. [europepmc]
• Mitochondria-Endoplasmic Reticulum Crosstalk in Parkinson's Disease: The Role of Brain Renin Angiotensin System Components. [europepmc]
• Initiation and progression of α-synuclein pathology in Parkinson's disease. [europepmc]
• Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43. [europepmc]
• Toothed Whales Have Black Neurons in the Blue Spot. [europepmc]
• The Proteome of Neuromelanin Granules in Dementia with Lewy Bodies. [europepmc]
• The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease. [europepmc]
• Neuronal SNCA transcription during Lewy body formation. [europepmc]
• Is There a Place for Lewy Bodies before and beyond Alpha-Synuclein Accumulation? Provocative Issues in Need of Solid Explanations. [europepmc]
• Navigating through the complexities of synucleinopathies: Insights into pathogenesis, heterogeneity, and future perspectives. [europepmc]
• α -Synuclein ubiquitination - functions in proteostasis and development of Lewy bodies. [europepmc]
• Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases. [europepmc]
• Neuropathology of Lewy body dementia: Lewy-related pathology, α-synuclein oligomers, and comorbid pathologies. [europepmc]
• The Enigma of Neuromelanin: How Animal Models Can Help Researchers to Understand the Link Between Pigments and Neurodegeneration. [europepmc]
• The Noradrenergic Brain in Parkinson's Disease. [europepmc]
• Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases [europepmc]

Related

• Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
• The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
• Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
• Lewy and his inclusion bodies: Discovery and rejection
• Sphingomyelin in Lewy Inclusion Bodies in Parkinson's Disease